https://www.marketscreener.com/quote/stock/SEAGEN-INC-10808/news/Seagen-and-RemeGen-Announce-Exclusive-Worldwide-License-and-Co-Development-Agreement-for-Disitamab-36109625/?utm_source=telegram&utm_medium=social&utm_campaign=share